Related Experiment Video

Updated: May 20, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

193

Limitations of locoregional and distant recurrence analysis after neoadjuvant chemotherapy

Janhavi Venkataraman1, Kefah Mokbel2

  • 1The London Breast Institute, Princess Grace Hospital, HCA Healthcare Private Limited, 42-52 Nottingham Place, London, W1U 5NY, UK. janhavivraman@gmail.com.

Breast Cancer Research and Treatment
|April 22, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

8.0K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.4K

Related Experiment Videos

Last Updated: May 20, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

193
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

8.0K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.4K

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

313
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
313

Articles linked to this work by shared authors, journal, and citation graph.

Breast-Conserving Surgery in Multicentric Breast Cancer: Evolving Evidence and Patient Selection.

Cancers·2026

OneMark™ breast localisation: integrating diagnosis and surgical guidance-a narrative review.

Translational breast cancer research : a journal focusing on translational research in breast cancer·2026

Post-CDK4/6 Inhibitor Therapeutic Approaches in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Current Evidence and Emerging Strategies-A Narrative Review.

Diagnostics (Basel, Switzerland)·2026

SCOUT MD™ for breast and axillary localisation: a narrative review toward a single radar-based platform.

Gland surgery·2026

Patient and Public Perceptions of Artificial Intelligence in Breast Imaging and Clinical Decision-Making: An Exploratory Cross-Sectional Survey Study.

Diagnostics (Basel, Switzerland)·2026

Reconsidering the Interpretation of "Recurrence-Free Survival" After Mastectomy for DCIS. Comment on Sae-sim et al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. Curr. Oncol. 2026, 33, 89.

Current oncology (Toronto, Ont.)·2026

Efficacy, safety, and biomarker analysis of neoadjuvant camrelizumab plus apatinib as a chemotherapy-free strategy for early-stage triple-negative breast cancer: a phase II study.

Breast cancer research and treatment·2026

Body mass index-associated gut microbial taxa and functional pathways in women with benign and malignant breast disease.

Breast cancer research and treatment·2026

History of the early development of aromatase inhibitors for treatment of breast cancer.

Breast cancer research and treatment·2026

Comment on "Effects of a sensorimotor-based, movement quality-focused intervention on functional mobility in breast cancer survivors: a multicenter randomized controlled trial".

Breast cancer research and treatment·2026

Validation of a novel prognostic staging system for breast cancer incorporating age at diagnosis.

Breast cancer research and treatment·2026

Factors associated with discordance between pathological and radiological tumor size and risk of re-excision in breast-conserving surgery: a post-hoc analysis within a randomized trial.

Breast cancer research and treatment·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us